A double-blinded, randomized controlled clinical trial of hydrogen inhalation therapy for idiopathic sudden sensorineural hearing loss

A double-blinded, randomized controlled clinical trial of hydrogen inhalation therapy for idiopathic sudden sensorineural hearing loss

BackgroundHydrogen (H2) has been reported to be effective in reducing hearing loss due to several causes in animal studies. However, no study has examined the effectiveness of H2 in treating hearing loss in humans. Thus, we investigated whether H2 is effective for the treatment of idiopathic sudden...

Full description

Bibliographic Details
Main Authors: Masahiro Okada, Hideo Ogawa, Taro Takagi, Eriko Nishihara, Tadashi Yoshida, Jun Hyodo, Yusuke Shinomori, Nobumitsu Honda, Takashi Fujiwara, Masato Teraoka, Hiroyuki Yamada, Shin-ichi Hirano, Naohito Hato
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Neuroscience
Subjects:
sudden deafness
hydrogen
inner ear
free radical
hearing loss
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2022.1024634/full

Internet

https://www.frontiersin.org/articles/10.3389/fnins.2022.1024634/full

Similar Items